VA Commonwealth University Massey Comprehensive Cancer Ctr.
Locations
Transplant Summary
Overview
We perform autologous, related/unrelated allogeneic, and cord blood transplants in adult and pediatric patients. We offer a range of immune effector cellular therapies. We have 21 adult and 4 pediatric beds, adult and pediatric clinics, and a dedicated cellular therapeutics laboratory. We are FACT accredited. This center has been performing allogeneic transplants since 1988 and has been an NMDP transplant center since September 1992.This center has been performing allogeneic transplants since 1988 and has been an NMDP transplant center since September 1992.
Attending physicians
Adult - Harold Chung, William Clark, John McCarty, Sneha Purvey, Baldeep Wirk
Pediatric - Jordyn Griffin, Marieka Helou, Elizabeth Krieger, Joseph Laver, India SislerTransplants performed
Marrow/PBSC, single cord, and double cordCord blood transplants
Adult and pediatricOther programs and services
CIT Ancillary Clinic operates on a medical home model with other disciplines embedded in the clinic i.e. Pulmonology, Adolescent Young Adult, Cardiology, Endocrinology, Psychiatry, and Neuro Oncology. Weekly clinical care conferences allow each patient to be evaluated by the clinical transplant, hematologic malignancy, and clinical research teams. This allows for a comprehensive review of all potential treatment options, including non-transplant therapies.
Caregiver classes are available online and nursing provides teaching at the bedside with patients and their caregivers. The Doorways offers the conveniences of home (thedoorways.org). Recommended $15 dollar donation per guest per day, referral necessary from VCUHS staff. Guests must live 30 miles or more from VCUHS. All Guests must have an adult caregiver present. Located 5 blocks from VCUHS. Free Shuttle service provided to and from VCUHS (8am- 5pm). After 5pm there is an after hours transportation service available.
We offer legal services through our Medical-Legal Partnership for oncology and pediatric patients.Patient survival information for this center
This center's actual 1-year survival results are below the expected rate for this center*.The survival information we have for this center includes ONLY:- Patients who had their FIRST ALLOGENEIC transplant (cells from a related or unrelated donor/cord blood) during 2020, 2021, 2022 and
- Who had their transplant at a U.S. transplant center, and
- Who had follow-up information provided by the transplant center for analysis
For this center, we have survival information for 144 patients.The actual 1-year survival of these patients is 71.5%.Compared to similar patients transplanted at all centers in the U.S., we expect that the 1-year survival for patients at this center to be in a range between 72.7% and 85.5%.For help with understanding these statistics, please see Understanding Transplant Outcomes.For overall survival for all patients transplanted with a specific disease, please see U.S. Patient Survival report (Opens in a new tab) at bloodcell.transplant.hrsa.gov.* The expected survival rate for a transplant center can be below, similar to, or above the range listed. This is based on comparing patient survival at all centers that treated patients with similar diseases.
The survival rate cannot tell how you will do with your transplant. Talk to your doctor to understand your prognosis or the likely course of your disease.
Total adult transplants
248
Transplants reported by the centers (from January 1, 2022 to December 31, 2023)
Marrow PBSC Cord blood Total AllogeneicRelated donorMarrow2PBSC33Cord blood0Total35Unrelated donorMarrow1PBSC50Cord blood0Total51Total allogeneicMarrow3PBSC83Cord blood0Total86AutologousMarrowBoth marrow & PBSC 162PBSC—Cord blood—Total162Total combinedMarrowBoth marrow & PBSC 248PBSC—Cord blood0Total248Total pediatric transplants
23
Transplants reported by the centers (from January 1, 2022 to December 31, 2023)
Marrow PBSC Cord blood Total AllogeneicRelated donorMarrow9PBSC0Cord blood0Total9Unrelated donorMarrow3PBSC2Cord blood0Total5Total allogeneicMarrow12PBSC2Cord blood0Total14AutologousMarrowBoth marrow & PBSC 9PBSC—Cord blood—Total9Total combinedMarrowBoth marrow & PBSC 23PBSC—Cord blood0Total23All Diseases
Number of transplants by age reported from January 1, 2022 to December 31st, 2023(includes marrow, PBSC and cord blood)
0-18 19-44 45-64 65+ Total Related 0-181119-441045-641865+5Total44Unrelated 0-18519-441745-642265+12Total56Autologous 0-18919-441745-648665+59Total171Total 0-182519-444445-6412665+76Total271Treatments may be similar for diseases within a group. It might be helpful to look at centers that have done transplants for a specific disease and centers that have done transplants for any corresponding broad disease categories.
Centers are not required to report autologous transplants so the numbers might be incomplete.
More information about transplants can be found:
- U.S. Transplant Data by Center (Opens in a new tab) report at blood cell.transplant.hrsa.gov
- List of diseases
Transplant center resources
NMDP patient navigators
Patient navigators can answer your questions about choosing a transplant center and provide support and education to help you throughout your transplant journey.
- Inside the United States: 1 (888) 999-6743
- Outside the United States: 1 (763) 406-3410. (Long distance or international charges may apply.)
Email: patientinfo@nmdp.org
More resources
- Choosing a transplant center
- Preparing for transplant
- Learn about transplant outcomes and treatment decisions (Opens in a new tab)
- Support and resources (including non-English materials)
- U.S. Transplant Data by Center (Opens in a new tab) at blood cell.transplant.hrsa.gov
This center has separate survivorship programs for adult and pediatric patients.
Please select the program you are interested in.